PRICE T ROWE ASSOCIATES INC /MD/ – Alnylam Pharmaceuticals, Inc. Transaction History
PRICE T ROWE ASSOCIATES INC /MD/ portfolio value:
$744.71M
portfolio value
PRICE T ROWE ASSOCIATES INC /MD/ quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -46.83% | -3.27M shares | -275.80M | $200.16 | 3.72M |
| Q2 2022 | share | Increase | +2.99% | 202.91K shares | -88.89M | $145.85 | 6.99M |
| Q1 2022 | share | Increase | +3.96% | 258.79K shares | 1.15M | $163.29 | 6.79M |
| Q4 2021 | share | Increase | +11.25% | 661.13K shares | -846K | $171.03 | 6.53M |
| Q3 2021 | share | Increase | +6.33% | 349.55K shares | 172.57M | $188.81 | 5.87M |
| Q2 2021 | share | Decrease | -0.91% | -50.53K shares | 149.37M | $169.52 | 5.52M |
| Q1 2021 | share | Decrease | -0.00% | -129 shares | 62.53M | $141.19 | 5.57M |
| Q4 2020 | share | Decrease | -7.31% | -439.50K shares | -151.13M | $129.97 | 5.57M |
| Q3 2020 | share | Decrease | -4.11% | -257.57K shares | -53.24M | $145.6 | 6.01M |
| Q2 2020 | share | Decrease | -0.24% | -15.33K shares | 244.58M | $148.11 | 6.27M |
| Q1 2020 | share | Increase | +17.50% | 936.66K shares | 68.13M | $108.85 | 6.28M |
| Q4 2019 | share | Increase | +9.57% | 467.43K shares | 223.54M | $115.17 | 5.35M |
| Q3 2019 | share | Increase | +39.19% | 1.37M shares | 138.15M | $80.42 | 4.88M |
| Q2 2019 | share | Increase | +0.72% | 25.02K shares | -70.95M | $72.56 | 3.50M |
| Q1 2019 | share | Decrease | -5.23% | -192.23K shares | 57.53M | $93.45 | 3.48M |
| Q4 2018 | share | Decrease | -12.50% | -524.93K shares | -99.64M | $72.91 | 3.67M |
| Q3 2018 | share | Decrease | -19.43% | -1.01M shares | -145.87M | $87.52 | 4.20M |
| Q2 2018 | share | Decrease | -58.52% | -7.35M shares | -983.48M | $98.49 | 5.21M |
| Q1 2018 | share | Increase | +2.75% | 336.09K shares | -57.22M | $119.1 | 12.56M |
| Q4 2017 | share | Increase | +42.83% | 3.66M shares | 547.94M | $127.05 | 12.23M |
| Q3 2017 | share | Increase | +28.44% | 1.89M shares | 474.4M | $117.49 | 8.56M |
| Q2 2017 | share | Increase | +60.00% | 2.50M shares | 318.28M | $79.76 | 6.66M |
| Q1 2017 | share | Increase | +0.10% | 4.25K shares | 57.71M | $51.25 | 4.16M |
| Q4 2016 | share | Increase | +3.44% | 138.30K shares | -116.95M | $37.44 | 4.16M |
| Q3 2016 | share | Increase | +0.73% | 29.26K shares | 51.09M | $67.78 | 4.02M |
| Q2 2016 | share | Increase | +211.21% | 2.71M shares | 141.14M | $55.49 | 3.99M |
| Q1 2016 | share | Increase | +3.74% | 46.23K shares | -35.92M | $62.77 | 1.28M |